Big Move For Denali Therapeutics Inc.
Thu, Aug 06, 2020 at 05:30 PM
Denali Therapeutics Inc. (DNLI:NASDAQ) soared at $31.66, representing a gain of 36.2%. On Wed 05 Aug 20, DNLI:NASDAQ hit a New 2-Week Intraday Low of $22.75. The stock appeared on our News Catalysts scanner on Thu 06 Aug 20 at 10:04 AM in the 'PATNERSHIP' category. From Wed 22 Jul 20, the stock recorded 40.00% Up Days and 45.45% Green Days
The share price of the company has been moving sideways in recent weeks.
About Denali Therapeutics Inc. (DNLI:NASDAQ)
Denali Therapeutics Inc is a clinical-stage biopharmaceutical company. The company is engaged in developing therapeutics for neurodegenerative diseases, including Alzheimer's disease, Parkinson's disease and amyotrophic lateral sclerosis.
Top 10 Gainers:
- ADTX (ADTX:NASDAQ), 93.38%
- American Virtual Cloud Technologies, Inc. (AVCT:NASDAQ), 72.52%
- Nova LifeStyle, Inc. (NVFY:NASDAQ), 50.63%
- GEE Group, Inc. (JOB:NYSEMKT), 50%
- OTRK (OTRK:NASDAQ), 43.58%
- Fiesta Restaurant Group, Inc. (FRGI:NASDAQ), 37.71%
- Denali Therapeutics Inc. (DNLI:NASDAQ), 36.23%
- JanOne Inc. (JAN:NASDAQ), 35.43%
- Celsius Holdings, Inc. (CELH:NASDAQ), 33.1%
- CBL & Associates Properties, Inc. (CBL:NYSE), 30.86%